These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3857074)

  • 1. Prediction of response of acute non-lymphocytic leukaemia to therapy with 'high dose' cytosine arabinoside.
    Peters WG; Willemze R; Colly LP; Colla L
    Br J Haematol; 1985 Apr; 59(4):733-4. PubMed ID: 3857074
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose cytosine arabinoside in the initial treatment of acute leukemia.
    Barnett MJ; Waxman JH; Richards MA; Ganesan TS; Bragman KS; Rohatiner AZ; Lister TA
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):133-8. PubMed ID: 3859927
    [No Abstract]   [Full Text] [Related]  

  • 3. Prediction of response of acute nonlymphocytic leukaemia to therapy with 'high dose' cytosine arabinoside.
    Preisler HD; Epstein J; Barcos M; Priore R; Raza A; Browman GP; Vogler R; Winton E; Grunwald H; Rai K
    Br J Haematol; 1984 Sep; 58(1):19-32. PubMed ID: 6466567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the characteristics of the bone marrow during therapy for acute non-lymphocytic leukemia: relationship to response to remission induction therapy.
    Preisler HD; Raza A; Azarnia N; Rakowsky I; Barcos M; Browman G; Booker L; Goldberg J; Gottleib A; Brennan J
    Eur J Cancer Clin Oncol; 1985 May; 21(5):563-71. PubMed ID: 3859416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone marrow changes in acute non-lymphocytic leukemia patients treated with low-dose Ara-C--implications of therapeutic mechanism].
    Lin SF; Liu HW; Chen JR; Chien CH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Sep; 3(9):612-7. PubMed ID: 3483023
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
    Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preliminary results of the treatment of non-lymphoblastic leukemia and bone marrow dysplasia with small doses of cytosine arabinoside].
    Brodzki LM
    Acta Haematol Pol; 1985; 16(1-2):85-9. PubMed ID: 3914171
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy for acute non-lymphocytic leukemia with low-dose cytosine arabinoside (Ara-C).
    Lin SF; Liu HW; Chen TP
    Nihon Ketsueki Gakkai Zasshi; 1990 Feb; 53(1):45-50. PubMed ID: 2330805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose cytosine arabinoside in the myelodysplastic syndromes and acute myelogenous leukemia.
    Roberts JD; Ershler WB; Tindle BH; Stewart JA
    Cancer; 1985 Sep; 56(5):1001-5. PubMed ID: 3860278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytosine arabinoside therapy for acute myeloid leukaemia in adults.
    Buchanan JG
    N Z Med J; 1971 Sep; 74(471):153-9. PubMed ID: 5289827
    [No Abstract]   [Full Text] [Related]  

  • 11. Accumulation of S-phase cells in the bone marrow of patients with acute leukemia by cytosine arabinoside.
    Büchner T; Barlogie B; Asseburg U; Hiddemann W; Kamanabroo D; Göhde W
    Blut; 1974 Apr; 28(4):299-300. PubMed ID: 4524531
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of early acute nonlymphatic leukemia with low dose cytosine arabinoside.
    Moloney WC; Rosenthal DS
    Haematol Blood Transfus; 1981; 26():59-62. PubMed ID: 7033074
    [No Abstract]   [Full Text] [Related]  

  • 13. [Electron microscopic bone marrow changes in acute leukemias before and after cytosin-arabinoside therapy].
    Ruzicka F; Weigerstorfer B
    Verh Dtsch Ges Inn Med; 1973; 79():369-72. PubMed ID: 4524459
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of acute myeloid leukemia in adults with a combination of daunomycin and cytosine-arabinoside].
    Brincker H
    Ugeskr Laeger; 1972 Oct; 134(42):2195-200. PubMed ID: 4563112
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of acute myelocytic leukemia with low-dose cytosine arabinoside: results of a pilot study in four patients.
    Hagenbeek A; Sizoo W; Löwenberg B
    Leuk Res; 1983; 7(3):443-6. PubMed ID: 6350731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute leukemia subsequent to sideroblastic anemia: response to low dose cytosine arabinoside].
    Tanaka M; Nagai H; Murase T; Fujiwara Y; Nakaide Y; Ohkita T
    Rinsho Ketsueki; 1988 Jan; 29(1):80-4. PubMed ID: 3164420
    [No Abstract]   [Full Text] [Related]  

  • 18. Predicting remission outcome in acute non-lymphocytic leukemia: general principles and their application to residual marrow leukemia.
    Browman GP; Preisler HD
    Leuk Res; 1992; 16(5):511-9. PubMed ID: 1625477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced kinetic perturbations of the marrow blasts in acute leukemia. Effects of the daunorubicin, cytosine arabinoside and 6-thioguanine combination.
    Amadori S; Petti MC; Mastrovincenzo C; Testa MG
    Acta Haematol; 1979; 61(5):237-42. PubMed ID: 111451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukemias and myelodysplastic syndromes.
    Tambone Reyes M; Bonaccorso R; Gebbia V; Tinnirello D; Di Salvo V; Ciulla A; Di Marco P; Mansueto S; Citarrella P
    J Chemother; 1989 Jul; 1(4 Suppl):1276-8. PubMed ID: 16312864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.